Nektar Therapeutics (NKTR)
$73.69-0.45%Close
BUYRECOVERY · day 49
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $1.4B
- Avg volume
- 1.0M
- Beta
- 1.16
- P/E (TTM)
- -11.00
- Short % float
- 34.39%
- Days to cover
- 8.6
- SI change
- -7.6%
- 1W
- +1.40%
- 1M
- +4.20%
- 3M
- +10.63%
- YTD
- +69.71%
- vs SPY 1W
- +2.59%
- vs SPY 1M
- +0.88%
- vs SPY 3M
- +8.24%
- vs SPY YTD
- +57.96%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- NRIXBUYNurix Therapeutics, Inc.BULLQ 13$26.27-1.68%
- STIMBUYNeuronetics, Inc.RECOVERYQ -9$2.89-3.67%
- ARMPBUYArmata Pharmaceuticals, Inc.RECOVERYQ -3$5.17+1.37%
- PALIBUYPalisade Bio, Inc.RECOVERYQ -14$2.01-4.29%
- VBIOSELLMalachite Innovations, Inc.CRISISQ -28$0.17+41.67%
- MSPRZSELLMSP Recovery, Inc.CRISISQ -19$0.01-75.00%
- SKINSELLThe Beauty Health CompanyRECOVERYQ -18$0.68+4.62%
- EVHBUYEvolent Health, Inc.RECOVERYQ -6$4.72-0.42%
- AVTRBUYAvantor, Inc.RECOVERYQ 2$14.26-1.38%
- SLGLSELLSol-Gel Technologies Ltd.BEARQ 11$77.39-0.44%
- QSIBUYQuantum-Si incorporatedRECOVERYQ -5$0.77-7.23%
- CCMBUYConcord Medical Services Holdings LimitedRECOVERYQ 5$4.98-5.86%
Industry peers
FMP comparable companies · ranked by market cap
- ELVNBUYEnliven Therapeutics, Inc.$4.4BBULLQ 15$61.15+2.22%
- RLAYBUYRelay Therapeutics, Inc.$4.3BBULLQ 4$19.76+1.65%
- AMLXBUYAmylyx Pharmaceuticals, Inc.$4.2BRECOVERYQ 10$38.15-1.32%
- ATAIBUYAtai Beckley Inc.$2.7BBULLQ -2$7.38+0.00%
- XNCRBUYXencor, Inc.$2.1BBULLQ 17$29.00+4.32%
- SNDXSELLSyndax Pharmaceuticals, Inc.$1.7BRECOVERYQ 18$19.57-0.41%
- INBXBUYInhibrx Biosciences Inc.$1.5BRECOVERYQ 33$104.94+1.26%
- ORICBUYORIC Pharmaceuticals, Inc.$1.4BBULLQ 4$13.46-5.21%
- IMTXSELLImmatics N.V.$1.2BCRISISQ 8$8.69-2.69%
- SANABUYSana Biotechnology, Inc.$1.1BRECOVERYQ -4$3.78-3.32%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 3
- VALUE
- 2
- GROWTH
- 17
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-22.8%
REV YoY-
ROE-38.0%
EPS YoY-
ROA-14.3%
GROSS99
OP-240
NET-288
[VALUATION]
P/E TTM-11.00
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B2.70
P/FCF-
EV/EBITDA-16.45
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E15.05
ALTMAN Z-
CURR RATIO10.42
ND/EBITDA-
BETA1.16
